Pfizer Inc (PFE)

$26.99 +0.22 (0.82%)
Market Cap 153.36B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.49
Forward PE 9.22
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 25,003,382
Avg Vol 47,040,574
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 20%
Beta 0.47
Analysts Sell
Price Target $28.94

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
TechTraderGrok
TechTraderGrok Mar. 24 at 8:04 PM
Bought $PFE at $27.01. From Grok: "" https://www.techtrader.ai/grokwall/?post=17245&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
indepth1
indepth1 Mar. 24 at 6:04 PM
$BRTX :✅️ 3 Big Pharma's & the 3 "Weight Loss" Patents for Japan, Australia & NOA to be patent for USA. ((EOP = European will cover 40 countries in 1 patent has been filed to be issued in mid 2026 = most all balance free world.)) But $BRTX's protection now in filing .✅️ 🔑 Big Pharma companies $PFE , Novo Nordisk and Eli Lilly) can Not publicly named $BRTX in mission statements. All 3 Big Pharma strategic actions, needs and several statements by all 3 align perfectly with needs for what BRTX's 3 patents cover is DD fact.🔑 👍 Catalyst for NEWS at ORS annual Meeting 3-28 to 31: A successful Type B meeting with the FDA in early 2026 confirmed an accelerated pathway for Phase 3 trials, making 👇 $BRTX a much more "de-risked" & attractive target for major pharmaceutical companies looking to acquire late-stage phase 2 assets 👇 &f und exclusive licensing agreements. 👍 🔑 Doing deductive reasoning of clearly obvious many reasons why licensing agreement with upfront cash funding of $35 to $ 75 million dollars is happening next with Big Pharma for $BRTX at 7 times Market Cap of only 7 million now 💰 ? 🔑
0 · Reply
dnpro
dnpro Mar. 24 at 6:01 PM
$SDGR I read about rumors about big pharma to buy it. Do you read something about it? $PFE $LLY $QQQ
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 24 at 5:44 PM
$PFE Close red
0 · Reply
LifeStyle_Of_The_Meek
LifeStyle_Of_The_Meek Mar. 24 at 5:02 PM
$PFE $GD “Ferrying an estimated 730,000 barrels of crude oil across the Atlantic, the tanker is flying a Russian flag. A Russian warship escorted it through the English Channel, where it was tracked by the Royal Navy for 48 hours, only to turn back as soon as the tanker was clear. While the Kremlin declined to confirm reports of Russian oil heading to Cuba, it also has made little effort to conceal its hand.”
0 · Reply
YoloAlfred
YoloAlfred Mar. 24 at 4:50 PM
$BRTX $BRTX $PFE $BRTX added more BRTX
0 · Reply
LadsAndGents
LadsAndGents Mar. 24 at 3:58 PM
$PFE 28 this month or next ?
1 · Reply
indepth1
indepth1 Mar. 24 at 3:48 PM
$BRTX DD Licensing & funding at Huge OSR Meeting 3-28 to 31: ✅️ There are very definitive hints in speculation by all 3 Big Pharma's that $BRTX will use the ORS conference 3 28 to 31 as the platform to make an announcement. ✅️ Forming 🔑 New strategic partnership with $PFE or 1 of 2 other Big Pharma's for upfront funding in cash of $35 to $75 +million dollars in licensing deal. The 3 very Required patents in weight loss are needed by all Big Pharma's in the 100 Billion dollar industory . 🔑 Funding also for 👍 research with more important detailed developments of BRTX-100. Important especially after recent positive regulatory alignments moved time line ahead on details in Phase 2 trials with the FDA in March.👍 Hinks on urgent needs for $BRTX 3 patents with ✅️ several statements by all 3 Big Pharma's in detailed DD research i have done in the last 2 weeks will become printed facts in 1 to 3 weeks ! ✅️ TIA for detailed in-depth DD with timely T/A by astutely observant DD posting members. .
0 · Reply
Quantumup
Quantumup Mar. 24 at 3:08 PM
Jefferies reiterated $CTMX Buy/$16, and said: We spoke w/ mgmt following recent Ph1a topline to clarify several outstanding questions. $PFE MRK RHHBY DSNKY $ABBV Here's what elseJefferies had to say: https://x.com/Quantumup1/status/2036459292417487341?s=20
0 · Reply
Magna141
Magna141 Mar. 24 at 3:07 PM
$ZVRA Been a fun ride, moving on to $PFE , a lot more products in the line up, with less drama. Wish all of you best of luck, its been great hanging out these last few months.
4 · Reply
Latest News on PFE
Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 24, 2026, 10:00 AM EDT - 6 hours ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

Mar 23, 2026, 12:46 PM EDT - 1 day ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

Mar 23, 2026, 10:35 AM EDT - 1 day ago

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

VALN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 9:36 AM EDT - 1 day ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

VALN

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Mar 23, 2026, 7:07 AM EDT - 1 day ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

VALN

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Mar 23, 2026, 7:02 AM EDT - 1 day ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

VALN

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Mar 23, 2026, 6:47 AM EDT - 1 day ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

VALN

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Mar 23, 2026, 6:45 AM EDT - 1 day ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

VALN

5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 2 days ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 20, 2026, 4:30 PM EDT - 3 days ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 19, 2026, 6:45 AM EDT - 5 days ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 6 days ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Pfizer: I'm Still Expecting A Massive Rebound

Mar 18, 2026, 9:00 AM EDT - 6 days ago

Pfizer: I'm Still Expecting A Massive Rebound

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 7:49 AM EDT - 7 days ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 17, 2026, 6:45 AM EDT - 7 days ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation

Mar 13, 2026, 5:01 PM EDT - 10 days ago

Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 15 days ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 15 days ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (March 2026)

Mar 7, 2026, 8:15 AM EST - 17 days ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (March 2026)

ADP ARCC BX CAG GLPI MPLX MSFT

Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies

Mar 6, 2026, 6:05 AM EST - 18 days ago

Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies

AMD GOOG GOOGL LLY NVDA NVO

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 18 days ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 18 days ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Seven S&P500 Ideal 'Safer' March Dividend Dogs

Mar 4, 2026, 11:31 AM EST - 20 days ago

Seven S&P500 Ideal 'Safer' March Dividend Dogs

AMCR ARE BBY BEN BXP CAG CCI

Pfizer's Portfolio Renewal In Progress - High Yields For The Patient

Mar 4, 2026, 9:09 AM EST - 20 days ago

Pfizer's Portfolio Renewal In Progress - High Yields For The Patient

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Mar 4, 2026, 8:55 AM EST - 20 days ago

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

SMWB

Pfizer's Quiet Cash Comeback

Mar 3, 2026, 9:50 AM EST - 21 days ago

Pfizer's Quiet Cash Comeback

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

Mar 3, 2026, 8:10 AM EST - 21 days ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

PRGO XRAY

Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 2, 2026, 1:27 PM EST - 22 days ago

Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 22 days ago

Pfizer CEO flags issues with FDA's vaccine leadership

The High Dividend Yield Bull Market: 3 Compelling 6% Yields

Mar 2, 2026, 4:51 AM EST - 22 days ago

The High Dividend Yield Bull Market: 3 Compelling 6% Yields

ABBV AMGN AVGO BTI DIV ENB GTY

14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)

Mar 1, 2026, 8:10 AM EST - 23 days ago

14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)

ARCC BBVA E EQNR ETD FINV GSL

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Feb 27, 2026, 10:00 AM EST - 25 days ago

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills

Feb 26, 2026, 7:48 AM EST - 26 days ago

5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills

BBY CAG EQR FRT KEY KMI LYB

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Feb 24, 2026, 2:29 PM EST - 4 weeks ago

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 4 weeks ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 4 weeks ago

Pfizer in diabetes drug deal with Sciwind Biosciences

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

Feb 23, 2026, 3:15 PM EST - 4 weeks ago

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

MRK MRNA

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Feb 23, 2026, 10:00 AM EST - 4 weeks ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer: A Risky 6.3% Yield For Income-Oriented Investors

Feb 20, 2026, 11:47 PM EST - 4 weeks ago

Pfizer: A Risky 6.3% Yield For Income-Oriented Investors

Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 4 weeks ago

Is There 25% Downside For Pfizer Stock?

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Feb 18, 2026, 11:30 AM EST - 4 weeks ago

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Pfizer: The Rebound Looks Unsustainable

Feb 17, 2026, 5:42 PM EST - 4 weeks ago

Pfizer: The Rebound Looks Unsustainable

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Feb 17, 2026, 6:45 AM EST - 5 weeks ago

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Prices, pipelines and patent cliffs: Inside pharma's big reset

Feb 13, 2026, 6:13 AM EST - 5 weeks ago

Prices, pipelines and patent cliffs: Inside pharma's big reset

AMGN LLY NVO

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 5 weeks ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ABT ADBE AMGN AVGO BAC BK

Pfizer: A Great Opportunity Post Earnings

Feb 11, 2026, 6:08 PM EST - 5 weeks ago

Pfizer: A Great Opportunity Post Earnings

2 Urgent Sells And 2 No Brainer Dividend Buys

Feb 11, 2026, 4:06 PM EST - 5 weeks ago

2 Urgent Sells And 2 No Brainer Dividend Buys

ABBV AEP AMGN BMY ESS HASI HD

Is Pfizer Stock Now A Value Trap?

Feb 11, 2026, 8:56 AM EST - 5 weeks ago

Is Pfizer Stock Now A Value Trap?

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Feb 10, 2026, 3:20 PM EST - 5 weeks ago

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity

Feb 8, 2026, 10:19 PM EST - 6 weeks ago

Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity

TechTraderGrok
TechTraderGrok Mar. 24 at 8:04 PM
Bought $PFE at $27.01. From Grok: "" https://www.techtrader.ai/grokwall/?post=17245&utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
indepth1
indepth1 Mar. 24 at 6:04 PM
$BRTX :✅️ 3 Big Pharma's & the 3 "Weight Loss" Patents for Japan, Australia & NOA to be patent for USA. ((EOP = European will cover 40 countries in 1 patent has been filed to be issued in mid 2026 = most all balance free world.)) But $BRTX's protection now in filing .✅️ 🔑 Big Pharma companies $PFE , Novo Nordisk and Eli Lilly) can Not publicly named $BRTX in mission statements. All 3 Big Pharma strategic actions, needs and several statements by all 3 align perfectly with needs for what BRTX's 3 patents cover is DD fact.🔑 👍 Catalyst for NEWS at ORS annual Meeting 3-28 to 31: A successful Type B meeting with the FDA in early 2026 confirmed an accelerated pathway for Phase 3 trials, making 👇 $BRTX a much more "de-risked" & attractive target for major pharmaceutical companies looking to acquire late-stage phase 2 assets 👇 &f und exclusive licensing agreements. 👍 🔑 Doing deductive reasoning of clearly obvious many reasons why licensing agreement with upfront cash funding of $35 to $ 75 million dollars is happening next with Big Pharma for $BRTX at 7 times Market Cap of only 7 million now 💰 ? 🔑
0 · Reply
dnpro
dnpro Mar. 24 at 6:01 PM
$SDGR I read about rumors about big pharma to buy it. Do you read something about it? $PFE $LLY $QQQ
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 24 at 5:44 PM
$PFE Close red
0 · Reply
LifeStyle_Of_The_Meek
LifeStyle_Of_The_Meek Mar. 24 at 5:02 PM
$PFE $GD “Ferrying an estimated 730,000 barrels of crude oil across the Atlantic, the tanker is flying a Russian flag. A Russian warship escorted it through the English Channel, where it was tracked by the Royal Navy for 48 hours, only to turn back as soon as the tanker was clear. While the Kremlin declined to confirm reports of Russian oil heading to Cuba, it also has made little effort to conceal its hand.”
0 · Reply
YoloAlfred
YoloAlfred Mar. 24 at 4:50 PM
$BRTX $BRTX $PFE $BRTX added more BRTX
0 · Reply
LadsAndGents
LadsAndGents Mar. 24 at 3:58 PM
$PFE 28 this month or next ?
1 · Reply
indepth1
indepth1 Mar. 24 at 3:48 PM
$BRTX DD Licensing & funding at Huge OSR Meeting 3-28 to 31: ✅️ There are very definitive hints in speculation by all 3 Big Pharma's that $BRTX will use the ORS conference 3 28 to 31 as the platform to make an announcement. ✅️ Forming 🔑 New strategic partnership with $PFE or 1 of 2 other Big Pharma's for upfront funding in cash of $35 to $75 +million dollars in licensing deal. The 3 very Required patents in weight loss are needed by all Big Pharma's in the 100 Billion dollar industory . 🔑 Funding also for 👍 research with more important detailed developments of BRTX-100. Important especially after recent positive regulatory alignments moved time line ahead on details in Phase 2 trials with the FDA in March.👍 Hinks on urgent needs for $BRTX 3 patents with ✅️ several statements by all 3 Big Pharma's in detailed DD research i have done in the last 2 weeks will become printed facts in 1 to 3 weeks ! ✅️ TIA for detailed in-depth DD with timely T/A by astutely observant DD posting members. .
0 · Reply
Quantumup
Quantumup Mar. 24 at 3:08 PM
Jefferies reiterated $CTMX Buy/$16, and said: We spoke w/ mgmt following recent Ph1a topline to clarify several outstanding questions. $PFE MRK RHHBY DSNKY $ABBV Here's what elseJefferies had to say: https://x.com/Quantumup1/status/2036459292417487341?s=20
0 · Reply
Magna141
Magna141 Mar. 24 at 3:07 PM
$ZVRA Been a fun ride, moving on to $PFE , a lot more products in the line up, with less drama. Wish all of you best of luck, its been great hanging out these last few months.
4 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Mar. 24 at 2:56 PM
$PFE - Soon?
0 · Reply
JFDI
JFDI Mar. 24 at 2:30 PM
$PFE Set 2 go.
0 · Reply
Hankjessie
Hankjessie Mar. 24 at 2:18 PM
$PFE every day I wait till they fire the worst CEO…… guy sux. When it happens, I go all in.
0 · Reply
doubleuptwice
doubleuptwice Mar. 24 at 2:09 PM
$PFE another green Tuesday
1 · Reply
erevnon
erevnon Mar. 24 at 2:04 PM
Guggenheim maintains Pfizer $PFE at Buy and raises the price target from $35 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
IndyOne
IndyOne Mar. 24 at 1:55 PM
$MRNA Follow the bread crumbs: October 2025: STET rumored Moderna "deal of significant scope" in discussion, buyout or massive partnership. December 2025: Stéphane Bancel, Moderna CEO, sold his six-level home in Boston where he has lived for +12 years. January 2026: Moderna and Merck announced five-year follow-up data from the Phase 2b KEYNOTE-942 trial showed a 49% reduction in the risk of recurrence or death. Keytruda goes off patent soon, Merck can use Moderna's mRNA-4157 (also known as V940 or intismeran autogene) a first-of-its-kind, personalized mRNA cancer vaccine to extend Keytruda protection. February 2026: Patent litigation resolved with payment from Moderna. Moderna wanted the decks clear, they could have fought this longer like Pfizer & Biontech. NO ROYALTIES! HUGE WIN. Likely buyout coming from $MRK $PFE $JNJ or $RHHBY
1 · Reply
DragonAlgo
DragonAlgo Mar. 24 at 1:46 PM
🐉 $PFE CALL — DragonAlgo® Signal Contract: PFE CALL Expiry: 2026-03-27 | Strike: $27.00 | Type: CALL Option Plan (premium): Entry: $0.21 Stop: $0.15 TP1: $0.27 TP2: $0.36 TP3: $0.50 Risk preset by model constraints. 🔗 https://dragonalgo.com
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 24 at 1:45 PM
$PFE I love when I talk shit and it goes green
0 · Reply
TalkMarkets
TalkMarkets Mar. 24 at 1:40 PM
Trading In The Fog Of War $PFE $ET $MU $AMAT $LMT https://talkmarkets.com/article/15e2ae6b-a2a1-493d-9164-f242a88d3214
0 · Reply
Willieberich
Willieberich Mar. 24 at 1:37 PM
$PFE added at 26.60 ...
0 · Reply
indepth1
indepth1 Mar. 24 at 1:37 PM
$BRTX $PFE
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 24 at 1:33 PM
$PFE who wants to come out and defend this POS today?
1 · Reply